A Phase 2 Study of KPT-330 in Metastatic Castrate Resistant Prostate Adenocarcinoma
Latest Information Update: 14 Jan 2014
At a glance
- Drugs Selinexor (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 14 Jan 2014 New trial record